The U.S. FDA has released a new draft guidance for drugmakers to aid them in developing new treatments for obesity. The new ...
US-based pharmaceutical company VYNE Therapeutics has completed enrolment in the randomised Phase IIb clinical trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback